SEC Filing Summary for Maraoui Claude

Maraoui Claude, President & CEO of Journey Medical Corp, was granted 49,277 restricted stock units on April 22, 2026, vesting over three years. Additionally, Claude was granted 82,915 stock options on the same date, also vesting over three years, with an exercise price of $5.04. These grants were made under the Issuer's 2015 Stock Plan, as amended. The filing indicates direct ownership of these securities following the transactions.